12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Deals

Kyowa Hakko Kirin, LIAI deal

Kyowa's Kyowa Hakko Kirin California Inc. subsidiary and the institute partnered to research and develop therapies for inflammatory and autoimmune indications. Under the six-year deal, Kyowa Hakko Kirin California will...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >